{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:16:50Z","timestamp":1791231410124,"version":"4.1.0"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,15]],"date-time":"2024-01-15T00:00:00Z","timestamp":1705276800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100013465","name":"AFM-Telethon","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013465","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","nmd-journal.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.nmd.2024.01.003","type":"journal-article","created":{"date-parts":[[2024,1,14]],"date-time":"2024-01-14T06:28:43Z","timestamp":1705213723000},"page":"6-15","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["An up-to-date myopathologic characterisation of facioscapulohumeral muscular dystrophy type 1 muscle biopsies shows sarcolemmal complement membrane attack complex deposits and increased skeletal muscle regeneration"],"prefix":"10.1016","volume":"36","author":[{"given":"Lisanne","family":"Hubregtse","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karlijn","family":"Bouman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ch\u00e9ryane","family":"Lama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saskia","family":"Lassche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"de Graaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Taglietti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benno","family":"K\u00fcsters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baptiste","family":"Periou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Relaix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baziel","family":"van Engelen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois-Jer\u00f4me","family":"Authier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicol C.","family":"Voermans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7871-8600","authenticated-orcid":false,"given":"Edoardo","family":"Malfatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nmd.2024.01.003_bib0001","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1212\/WNL.0000000000000797","article-title":"EPopulation-based incidence and prevalence of facioscapulohumeral dystrophy","volume":"83","author":"Deenen","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2024.01.003_bib0002","unstructured":"Preston M.K., Tawil R., Wang L.H. Facioscapulohumeral Muscular Dystrophy. GeneReviews\u00ae [Updated 2020 Feb 6], University of Washington, Seattle; 1999."},{"key":"10.1016\/j.nmd.2024.01.003_bib0003","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1212\/CON.0000000000000399","article-title":"Facioscapulohumeral Muscular Dystrophy","volume":"22","author":"Statland","year":"2016","journal-title":"CONTINUUM Lifelong Learn Neurol"},{"key":"10.1016\/j.nmd.2024.01.003_bib0004","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1212\/CON.0000000000000801","article-title":"Facioscapulohumeral Muscular Dystrophies","volume":"25","author":"Wagner","year":"2019","journal-title":"CONTINUUM Lifelong Learn Neurol"},{"key":"10.1016\/j.nmd.2024.01.003_bib0005","doi-asserted-by":"crossref","DOI":"10.1007\/s11910-016-0667-0","article-title":"Facioscapulohumeral dystrophy","volume":"16","author":"Wang","year":"2016","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.1016\/j.nmd.2024.01.003_bib0006","doi-asserted-by":"crossref","unstructured":"Lemmers R.J.L.F., Vliet PJ Van Der, Klooster R., Sacconi S., Dauwerse J.G., Snider L., et al. A unifying genetic model for facioscapulohumeral muscular dystrophy 2015;329:1650\u20133. https:\/\/doi.org\/10.1126\/science.1189044.A.","DOI":"10.1126\/science.1189044"},{"key":"10.1016\/j.nmd.2024.01.003_bib0007","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.3390\/jcm9092886","article-title":"Therapeutic strategies targeting DUX4 in FSHD","volume":"9","author":"Le Gall","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.nmd.2024.01.003_bib0008","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1582-4934.2012.01647.x","article-title":"DUX4 expression in FSHD muscle cells: how could such a rare protein cause a myopathy?","volume":"17","author":"Tassin","year":"2013","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.nmd.2024.01.003_bib0009","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0387-7604(12)80128-8","article-title":"Facioscapulohumeral muscular dystrophy: muscle fibre type analysis with particular reference to small angular fibres","volume":"13","author":"Lin","year":"1991","journal-title":"Brain Dev"},{"key":"10.1016\/j.nmd.2024.01.003_bib0010","doi-asserted-by":"crossref","first-page":"73573","DOI":"10.1371\/journal.pone.0073573","article-title":"Altered expression of cyclin A 1 in muscle of patients with facioscapulohumeral muscle dystrophy (FSHD-1)","volume":"8","author":"Pakula","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.nmd.2024.01.003_bib0011","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1093\/jnen\/60.3.302","article-title":"Caspase 3 expression correlates with skeletal muscle apoptosis in Duchenne and facioscapulo human muscular dystrophy. A potential target for pharmacological treatment?","volume":"60","author":"Sandri","year":"2001","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.nmd.2024.01.003_bib0012","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/ane.12109","article-title":"Muscle regeneration and inflammation in patients with facioscapulohumeral muscular dystrophy","volume":"128","author":"Hauerslev","year":"2013","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.nmd.2024.01.003_bib0013","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3233\/JND-150077","article-title":"Immunohistochemical characterization of facioscapulohumeralmuscular dystrophy muscle biopsies","volume":"2","author":"Statland","year":"2015","journal-title":"J Neuromuscul Dis"},{"key":"10.1016\/j.nmd.2024.01.003_bib0014","unstructured":"Padberg GWAM. Facioscapulohumeral disease. 1982."},{"key":"10.1016\/j.nmd.2024.01.003_bib0015","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s10875-010-9474-6","article-title":"CD8+ T cells in facioscapulohumeral muscular dystrophy patients with inflammatory features at muscle MRI","volume":"31","author":"Frisullo","year":"2011","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.nmd.2024.01.003_bib0016","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1002\/mus.880181312","article-title":"Inflammatory response in facioscapulohumeral muscular dystrophy (FSHD): immunocytochemical and genetic analyses","volume":"18","author":"Arahata","year":"1995","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2024.01.003_bib0017","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/mus.24621","article-title":"Muscle pathology grade for facioscapulohumeral muscular dystrophy biopsies","volume":"52","author":"Statland","year":"2015","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2024.01.003_bib0018","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1093\/hmg\/ddaa164","article-title":"Skeletal muscle regeneration in facioscapulohumeral muscular dystrophy is correlated with pathological severity","volume":"29","author":"Banerji","year":"2020","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nmd.2024.01.003_bib0019","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/mt.2015.200","article-title":"CRISPR\/dCas9-mediated transcriptional inhibition ameliorates the epigenetic dysregulation at D4Z4 and represses DUX4-fl in FSH muscular dystrophy","volume":"24","author":"Himeda","year":"2016","journal-title":"Mol Therapy"},{"key":"10.1016\/j.nmd.2024.01.003_bib0020","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.omtm.2020.12.001","article-title":"Targeted epigenetic repression by CRISPR \/dSaCas9 suppresses pathogenic DUX4-fl expression in FSHD","volume":"20","author":"Himeda","year":"2021","journal-title":"Mol Ther Methods Clin Dev"},{"key":"10.1016\/j.nmd.2024.01.003_bib0021","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1172\/JCI136873","article-title":"Correction of muscular dystrophies by CRISPR gene editing","volume":"130","author":"Chemello","year":"2020","journal-title":"J Clinic Investig"},{"key":"10.1016\/j.nmd.2024.01.003_bib0022","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1152\/physrev.00046.2017","article-title":"Myoediting: toward prevention of muscular dystrophy by therapeutic genome editing","volume":"98","author":"Zhang","year":"2018","journal-title":"Physiol Rev"},{"key":"10.1016\/j.nmd.2024.01.003_bib0023","doi-asserted-by":"crossref","unstructured":"Joubert R., Mariot V., Charpentier M., Concordet J.P., Dumonceaux J. Gene Editing Targeting the DUX4 Polyadenylation Signal : a Therapy for FSHD ? 2021.","DOI":"10.3390\/jpm11010007"},{"key":"10.1016\/j.nmd.2024.01.003_bib0024","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1124\/jpet.119.259663","article-title":"Clinically advanced p38 inhibitors suppress DUX4 expression in cellular and animal models of facioscapulohumeral muscular dystrophys","volume":"370","author":"Oliva","year":"2019","journal-title":"J Pharmacol Experimental Therapeutics"},{"key":"10.1016\/j.nmd.2024.01.003_bib0025","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/j.bbamcr.2007.03.010","article-title":"p38 MAP-Kinases pathway regulation, function and role in human diseases","volume":"1773","author":"Cuenda","year":"2007","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"issue":"1","key":"10.1016\/j.nmd.2024.01.003_bib0026","doi-asserted-by":"crossref","DOI":"10.1186\/s13395-022-00287-8","article-title":"Meeting report: the 2021 FSHD international research congress","volume":"12","author":"Jagannathan","year":"2022","journal-title":"Skelet Muscle"},{"key":"10.1016\/j.nmd.2024.01.003_bib0027","unstructured":"Fulcrum Therapeutics Announces Results from ReDUX4 Trial with Losmapimod in Facioscapulohumeral Muscular Dystrophy (FSHD) Demonstrating Slowed Disease Progression and Improved Function \u00bb Fulcrum Therapeutics n.d. https:\/\/ir.fulcrumtx.com\/news-releases\/news-release-details\/fulcrum-therapeutics-announces-results-redux4-trial-losmapimod\/(accessed May 2, 2022)."},{"key":"10.1016\/j.nmd.2024.01.003_bib0028","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.devcel.2011.11.013","article-title":"Article DUX4 activates germline genes, retroelements, and immune mediators : implications for facioscapulohumeral dystrophy","volume":"22","author":"Geng","year":"2012","journal-title":"Dev Cell"},{"key":"10.1016\/j.nmd.2024.01.003_bib0029","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pgen.1001181","article-title":"Facioscapulohumeral dystrophy: incomplete suppression of a retrotransposed gene","volume":"6","author":"Snider","year":"2010","journal-title":"PLoS Genet"},{"key":"10.1016\/j.nmd.2024.01.003_bib0030","doi-asserted-by":"crossref","first-page":"5342","DOI":"10.1093\/hmg\/ddu251","article-title":"DUX4-induced gene expression is the major molecular signature in FSHD skeletal muscle","volume":"23","author":"Yao","year":"2014","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nmd.2024.01.003_bib0031","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-017-01200-4","article-title":"PAX7 target genes are globally repressed in facioscapulohumeral muscular dystrophy skeletal muscle","volume":"8","author":"Banerji","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.nmd.2024.01.003_bib0032","first-page":"495","article-title":"Correlation between quantitative MRI and muscle histopathology in muscle biopsies from healthy controls and patients with IBM","volume":"7","author":"Lassche","year":"2020","journal-title":"FSHD and OPMD"},{"key":"10.1016\/j.nmd.2024.01.003_bib0033","doi-asserted-by":"crossref","first-page":"e1157","DOI":"10.1212\/WNL.0000000000008977","article-title":"Preserved single muscle fibre specific force in facioscapulohumeral muscular dystrophy","volume":"94","author":"Lassche","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2024.01.003_bib0034","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/mus.27074","article-title":"Reduced specific force in patients with mild and severe facioscapulohumeral muscular dystrophy","volume":"63","author":"Lassche","year":"2021","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2024.01.003_bib0035","doi-asserted-by":"crossref","first-page":"e1054","DOI":"10.1212\/WNL.0000000000011412","article-title":"CLIA laboratory testing for facioscapulohumeral dystrophy: a retrospective analysis","volume":"96","author":"Rieken","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2024.01.003_bib0036","doi-asserted-by":"crossref","DOI":"10.1186\/2051-5960-2-44","article-title":"Muscle histopathology in nebulin-related nemaline myopathy: ultrastrastructural findings correlated to disease severity and genotype","volume":"2","author":"Malfatti","year":"2014","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/j.nmd.2024.01.003_bib0037","doi-asserted-by":"crossref","unstructured":"Schindelin J., Arganda-carreras I., Frise E., Kaynig V., Pietzsch T., Preibisch S., et al. Fiji - an Open Source platform for biological image analysis 2019;9. https:\/\/doi.org\/10.1038\/nmeth.2019.Fiji.","DOI":"10.1038\/nmeth.2019"},{"key":"10.1016\/j.nmd.2024.01.003_bib0038","doi-asserted-by":"crossref","unstructured":"Statland J.M., Donlin- C.M., Tapscott S.J., Lemmers R.J.L.F. Milder phenotype in facioscapulohumeral dystrophy with 7 \u201310 residual D4Z4 repeats 2015:2147\u201350.","DOI":"10.1212\/WNL.0000000000002217"},{"key":"10.1016\/j.nmd.2024.01.003_bib0039","doi-asserted-by":"crossref","unstructured":"Zernov N., Skoblov M. Genotype-phenotype correlations in FSHD 2019;12:0\u20136.","DOI":"10.1186\/s12920-019-0488-5"},{"key":"10.1016\/j.nmd.2024.01.003_bib0040","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s13311-018-00675-3","article-title":"Facioscapulohumeral muscular dystrophy: update on pathogenesis and future treatments","volume":"15","author":"Hamel","year":"2018","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.nmd.2024.01.003_bib0041","doi-asserted-by":"crossref","unstructured":"Tawil R., Forrester T.J., Griggs R.C., Mendell J., Kissel S.J., Mcdermott M., et al. Evidence for Anticipation and Association of Deletion Size w i t h Severity in Facioscapulohumerd Muscular Dystrophy 1996:744\u20138.","DOI":"10.1002\/ana.410390610"},{"key":"10.1016\/j.nmd.2024.01.003_bib0043","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/(SICI)1097-4598(199701)20:1<92::AID-MUS12>3.0.CO;2-3","article-title":"Expression of CD59, a regulator of the membrane attack complex of complement, on human skeletal muscle fibres","volume":"20","author":"Navenot","year":"1997","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2024.01.003_bib0042","doi-asserted-by":"crossref","first-page":"5655","DOI":"10.1073\/pnas.75.11.5655","article-title":"Molecular nature of the complement lesion","volume":"75","author":"Bhakdi","year":"1978","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.nmd.2024.01.003_bib0044","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.4049\/jimmunol.156.9.3402","article-title":"Human skeletal myoblasts spontaneously activate allogeneic complement but are resistant to killing","volume":"156","author":"Gasque","year":"1996","journal-title":"J Immunol"},{"key":"10.1016\/j.nmd.2024.01.003_bib0045","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.4049\/jimmunol.144.9.3478","article-title":"The complement-inhibitory activity of CD59 resides in its capacity to block incorporation of C9 into membrane C5b-9","volume":"144","author":"Rollins","year":"1990","journal-title":"J Immunol"},{"key":"10.1016\/j.nmd.2024.01.003_bib0046","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/BF01837366","article-title":"Membrane proteins that protect against complement lysis","volume":"15","author":"Morgan","year":"1994","journal-title":"Springer Semin Immunopathol"},{"key":"10.1016\/j.nmd.2024.01.003_bib0047","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1212\/WNL.50.1.41","article-title":"Unexpected sarcolemmal complement membrane attack complex deposits on nonnecrotic muscle fibres in muscular dystrophies","volume":"50","author":"Spuler","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2024.01.003_bib0048","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1093\/hmg\/ddab364","article-title":"Elevated plasma complement components in facioscapulohumeral dystrophy","volume":"31","author":"Wong","year":"2022","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nmd.2024.01.003_bib0049","doi-asserted-by":"crossref","first-page":"16234","DOI":"10.1073\/pnas.1209508109","article-title":"Transcriptional profiling in facioscapulohumeral muscular dystrophy to identify candidate biomarkers","volume":"109","author":"Rahimov","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.nmd.2024.01.003_bib0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0038779","article-title":"Different molecular signatures in magnetic resonance imaging-staged facioscapulohumeral muscular dystrophy muscles","volume":"7","author":"Tasca","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.nmd.2024.01.003_bib0052","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1212\/WNL.22.4.335","article-title":"Inflammatory myopathy with facioscapulohumeral distribution","volume":"22","author":"Munsat","year":"1972","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2024.01.003_bib0051","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/BF00313705","article-title":"Familial myopathies with restricted distribution, facial weakness and inflammatory changes in affected muscles","volume":"231","author":"Bacq","year":"1985","journal-title":"J Neurol"},{"key":"10.1016\/j.nmd.2024.01.003_bib0053","first-page":"99","article-title":"The histologic diagnosis of neuromuscular diseases: a review of 79 biopsies","volume":"47","author":"Brooke","year":"1966","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.nmd.2024.01.003_bib0054","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/ana.410160206","article-title":"Monoclonal antibody analysis of mononuclear cells in myopathies. I: quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibres invaded by T cells","volume":"16","author":"Arahata","year":"1984","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nmd.2024.01.003_bib0055","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1038\/emboj.2008.201","article-title":"An isogenetic myoblast expression screen identifies DUX4-mediated FSHD-associated molecular pathologies","volume":"27","author":"Bosnakovski","year":"2008","journal-title":"EMBO J"},{"key":"10.1016\/j.nmd.2024.01.003_bib0056","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.nmd.2007.04.002","article-title":"The DUX4 gene at the FSHD1A locus encodes a pro-apoptotic protein","volume":"17","author":"Kowaljow","year":"2007","journal-title":"Neuromuscular Disorders"},{"key":"10.1016\/j.nmd.2024.01.003_bib0057","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1582-4934.2008.00368.x","article-title":"Myoblasts from affected and non-affected FSHD muscles exhibit morphological differentiation defects","volume":"14","author":"Barro","year":"2010","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.nmd.2024.01.003_bib0058","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1000559","article-title":"Specific loss of histone H3 lysine 9 trimethylation and HP1gamma\/cohesin binding at D4Z4 repeats is associated with facioscapulohumeral dystrophy (FSHD)","volume":"5","author":"Zeng","year":"2009","journal-title":"PLoS Genet"},{"key":"10.1016\/j.nmd.2024.01.003_bib0059","doi-asserted-by":"crossref","first-page":"3816","DOI":"10.1242\/jcs.180372","article-title":"DUX4 induces a transcriptome more characteristic of a less-differentiated cell state and inhibits myogenesis","volume":"129","author":"Knopp","year":"2016","journal-title":"J Cell Sci"},{"key":"10.1016\/j.nmd.2024.01.003_bib0060","first-page":"139","article-title":"Immunobiology of inherited muscular dystrophies","volume":"176","author":"Tidball","year":"2016","journal-title":"Physiol Behav"},{"key":"10.1016\/j.nmd.2024.01.003_bib0061","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.devcel.2019.06.011","article-title":"DUX4 suppresses MHC class I to promote cancer immune evasion and resistance to checkpoint blockade","volume":"50","author":"Chew","year":"2019","journal-title":"Dev Cell"},{"key":"10.1016\/j.nmd.2024.01.003_bib0062","doi-asserted-by":"crossref","unstructured":"Banerji C.R.S., Henderson D., Tawil R.N., Zammit P.S. Skeletal muscle regeneration in facioscapulohumeral muscular dystrophy is correlated with pathological severity 2020;29:2746\u201360. https:\/\/doi.org\/10.1093\/hmg\/ddaa164.","DOI":"10.1093\/hmg\/ddaa164"},{"key":"10.1016\/j.nmd.2024.01.003_bib0063","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-04817-8","article-title":"Facioscapulohumeral dystrophy transcriptome signatures correlate with different stages of disease and are marked by different MRI biomarkers","volume":"12","author":"van den Heuvel","year":"2022","journal-title":"Sci Rep"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896624000026?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896624000026?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T19:33:43Z","timestamp":1731785623000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896624000026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":63,"alternative-id":["S0960896624000026"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2024.01.003","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An up-to-date myopathologic characterisation of facioscapulohumeral muscular dystrophy type 1 muscle biopsies shows sarcolemmal complement membrane attack complex deposits and increased skeletal muscle regeneration","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2024.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}